NCT01812772

Brief Summary

RESEARCH QUESTION Do ureteric stents with tethers, left in-situ for 1-2 weeks, increase the rate of stent bacterial colonization, urinary bacterial colonization and stent related lower urinary tract symptoms compared to stents without tethers? HYPOTHESIS We hypothesize that ureteral double-J stents with tethers increase the rate of stent bacterial colonization, but do not increase the rate of urinary bacterial colonization or stent related lower urinary tract symptoms compared to stents without tethers when left in-situ for 1-2 weeks.

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
11

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Mar 2013

Geographic Reach
1 country

1 active site

Status
terminated

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

March 1, 2013

Completed
13 days until next milestone

First Submitted

Initial submission to the registry

March 14, 2013

Completed
4 days until next milestone

First Posted

Study publicly available on registry

March 18, 2013

Completed
11 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

February 1, 2014

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

February 1, 2014

Completed
Last Updated

May 21, 2015

Status Verified

February 1, 2014

Enrollment Period

11 months

First QC Date

March 14, 2013

Last Update Submit

May 19, 2015

Conditions

Keywords

urinary stentsureteroscopy

Outcome Measures

Primary Outcomes (1)

  • The difference in stent related lower urinary tract symptoms based on mean scores from the Ureteral Stent Symptoms questionnaires

    The Ureteral Stent Symptoms Questionnaires will be completed before the procedure, 1 week after the procedure and 1 month after the stent was removed (5 weeks post procedure)

Secondary Outcomes (1)

  • the rate of stent bacterial colonization

    1 week post procedure

Study Arms (2)

Double J-stent with a long tether

EXPERIMENTAL

Following ureteroscopy patients will have placed a double J-stent with a long tether.

Device: Double J-stent with a long tether

Double J-stent without a long tether

ACTIVE COMPARATOR

Following ureteroscopy patients will have a double J-stent placed without a long tether

Device: Double J-stent without a long tether

Interventions

Patients will receive a double-J stent placement with a long tether following ureteroscopy.

Double J-stent with a long tether

Patients will receive a double-J stent placement without a long tether following ureteroscopy.

Double J-stent without a long tether

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Age over 18 years
  • First presentation for ureteroscopy for this particular stone
  • Planned insertion of a double J-stent
  • Follow-up conducted at St. Michael's Hospital

You may not qualify if:

  • Age \<18years
  • Preexisting stent in place
  • Bilateral ureteric stents to be inserted
  • Patients with congenital kidney anomalies (horseshoe kidney, ectopic kidney, etc.)
  • Patients with an indwelling foley catheter
  • Patients with neurogenic bladder, chronic prostatitis, painful bladder syndrome or interstitial cystitis
  • Patients with a urinary diversion (ileal conduit, ileal neobladder)
  • Patient currently taking an α-blocker (alfuzosin, terazosin,tamsulosin, prazosin)
  • Active urinary tract infection or positive screening urine culture at preadmission
  • Pregnancy
  • Patients who will not be returning to St. Michael's Hospital for follow-up

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

St. Michael Hospital

Toronto, Ontario, M5B 1W8, Canada

Location

MeSH Terms

Conditions

Kidney Calculi

Condition Hierarchy (Ancestors)

NephrolithiasisKidney DiseasesUrologic DiseasesFemale Urogenital DiseasesFemale Urogenital Diseases and Pregnancy ComplicationsUrogenital DiseasesUrolithiasisUrinary CalculiMale Urogenital DiseasesCalculiPathological Conditions, AnatomicalPathological Conditions, Signs and Symptoms

Study Officials

  • R. John D Honey, MD FRCSC

    Unity Health Toronto

    PRINCIPAL INVESTIGATOR
  • Kenneth T Pace, MD FRCSC

    Unity Health Toronto

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

March 14, 2013

First Posted

March 18, 2013

Study Start

March 1, 2013

Primary Completion

February 1, 2014

Study Completion

February 1, 2014

Last Updated

May 21, 2015

Record last verified: 2014-02

Locations